Joe David – CEO – Elementos (ASX:ELT) is committed to the safe and environmentally conscious exploration, development, and production of its global tin projects. The company owns two world class tin projects with large resource bases and significant exploration potential in mining-friendly jurisdictions.
Copyright 2024 – Finance News Network
Source: Finance News Network
10 Jun 2021 - Calima Energy Limited (ASX:CE1) Executive Chairman Glenn Whiddon provides an update on production at the company's projects in British Columbia and its plans for an active, low-risk drilling program developing proven reserves.
Read More16 Sep 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the company’s high-grade exploration results from its northern NSW project, plus how it’s poised to benefit from the rise of ‘critical minerals’ designation.
Read More17 Mar 2025 - LAG-3 and the Role of Immune Checkpoints in Cancer Treatment
Read More11 Sep 2024 - Linius Technologies Limited (ASX:LNU) CEO James Brennan discusses the company's recent capital raise, partnerships with Prime Focus, Magnify and Avid, and the launch of Captivate, a platform that enables broadcasters to offer personalised video content and compete with social media giants like TikTok and YouTube.
Read More12 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager Brett McNeill discuss the FY25 full-year results of Djerriwarrh Investments (ASX:DJW).
Read More11 Apr 2022 - Lake Resources Limited (ASX:LKE) Managing Director Steve Promnitz discusses offtake MOUs with Hanwa and Ford.
Read More24 Nov 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director Dr Michael Baker discusses the company's technology to convert solid dose drugs into oral sprays and the outlook for the year ahead.
Read More23 Dec 2019 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO, James McBrayer talks about the company's joint venture to expand Positron Emission Tomography (PET) diagnostics business opportunities for NSW and Australia.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More29 Jan 2021 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its recent cap raising to support rapid USA commercialisation for Technegas following USFDA approval targeted in Q2 2021.
Read More
